Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 32NIH 9NETWORK 2INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 2CNS 2

Conditions

Central Nervous System Neoplasms 107Neuroblastoma 64Brain Neoplasms 64Astrocytoma 59Glioblastoma 52Oligodendroglioma 42Medulloblastoma 36Gliosarcoma 34Glioma 28Optic Nerve Glioma 20Familial ependymoma 19Choroid Plexus Neoplasms 19Sarcoma 15Rhabdoid Tumor 15Lymphoma 14Precursor Cell Lymphoblastic Leukemia-Lymphoma 12Osteosarcoma 12Neoplasm Metastasis 12Ependymoma 12Meningioma 11Recurrence 10Melanoma 10Spinal Cord Neoplasms 9Leukemia 9Burkitt Lymphoma 9Testicular Neoplasms 8Ovarian Neoplasms 8Neoplasms 8Dendritic Cell Sarcoma, Interdigitating 8Wilms Tumor 7

Interventions

lonafarnib 1Temozolomide 1Imatinib Mesylate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NETWORK × Glioma, Subependymal × CNS × Clear all
NCT00083096 2015-02-10

Lonafarnib and Temozolomide in Treating Patients With Recurrent Primary Supratentorial Gliomas

European Organisation for Research and Treatment of Cancer - EORTC

Phase 1 Unknown
30 enrolled
CNSSarcoma

Astrocytoma, Brain Neoplasms, Ependymoma, Glioblastoma, Glioma, Oligodendroglioma, Central Nervous System Neoplasms, Glioma, Subependymal, Gliosarcoma

NCT00039364 2012-07-24

Imatinib Mesylate in Treating Patients With Gliomas

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Completed
112 enrolled
CNSSarcoma

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Oligodendroglioma, Central Nervous System Neoplasms, Glioma, Subependymal, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡